STOCK TITAN

Enhabit SEC Filings

EHAB NYSE

Welcome to our dedicated page for Enhabit SEC filings (Ticker: EHAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Medicare reimbursement tables, patient-day metrics, and hospice turnover data are scattered across hundreds of pages of Enhabit’s disclosures. If parsing those figures in the latest Enhabit annual report 10-K simplified seems daunting, you’re not alone. Healthcare accounting rules create footnotes that read like another language. Stock Titan’s AI turns that language into clear insights, making Enhabit SEC filings explained simply. Whether you’re scanning for regulatory risks or auditing segment margins, our platform surfaces what matters before you wade through dense jargon.

Need the next Enhabit quarterly earnings report 10-Q filing or an alert on Enhabit Form 4 insider transactions real-time? Our engine pulls every document the moment it hits EDGAR and delivers AI-powered summaries in seconds. Investors searching for:

  • Enhabit insider trading Form 4 transactions
  • Enhabit proxy statement executive compensation
  • Enhabit 8-K material events explained
  • Enhabit earnings report filing analysis

receive a single dashboard that connects each form to real questions: What did executives buy, how did home-health margins shift, and did CMS rule changes impact revenue guidance?

Understanding Enhabit SEC documents with AI also means context. Our tools highlight hospice census trends, regional payor mixes, and quality-of-care metrics buried deep in footnotes. Curious about Enhabit executive stock transactions Form 4 ahead of a rate update? Want a red-lined comparison that shows how the new filing differs from last year? Stock Titan provides real-time updates, side-by-side comparisons, and plain-English explanations, so you can decide faster, act sooner, and focus on the fundamentals driving home-health performance.

Rhea-AI Summary

Enhabit, Inc. (EHAB) director Erin Hoeflinger purchased 2,969 shares of the company's common stock on 10/10/2025 at a price of $8 per share. After the transaction the reporting person beneficially owned 76,325 shares. The Form 4 was filed as an individual filing and is signed by an attorney in fact.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Stuart M. McGuigan, a director of Enhabit, Inc. (EHAB), reported a purchase of 2,344 shares of the company's common stock on 10/10/2025 at a price of $8 per share. After the transaction he beneficially owns 72,245 shares. The Form 4 was filed as a single reporting person filing and signed by an attorney-in-fact, Sarah W. Braley, on 10/10/2025. The filing discloses a routine insider purchase by a board member with no derivative transactions reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Enhabit, Inc. (EHAB) director Gregory S. Rush acquired $8 per share on 10/10/2025, purchasing 3,125 shares and increasing his direct beneficial ownership to 76,043 shares. The transaction is reported on a Form 4 filed under Section 16, indicating an insider purchase rather than a derivative or sale. This purchase reflects a direct purchase of common stock and was signed by an attorney-in-fact on behalf of the reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Insider purchase reported: A director of Enhabit, Inc. (EHAB) acquired 2,344 shares of common stock on 10/10/2025 at a price of $8 per share. After the transaction the reporting person beneficially owned 18,117 shares. The Form 4 was filed by a single reporting person and signed by an attorney-in-fact.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Director Mark W. Ohlendorf reported a non-derivative purchase of 2,344 shares of Enhabit, Inc. (EHAB) on 10/10/2025 at a reported price of $8 per share. After the transaction he beneficially owned 42,646 shares. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person. No derivative transactions or additional explanatory remarks were disclosed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Insider purchase reported: A Form 4 shows director Charles M. Elson acquired 2,344 shares of Enhabit, Inc. (EHAB) on 10/10/2025 at a price of $8 per share. After the transaction he beneficially owns 77,417 shares. The filing was signed by an attorney-in-fact on 10/10/2025. The report lists the transaction as a direct acquisition by the reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Insider purchase recorded on Form 4. A director, Jeffrey Bolton, purchased 4,688 shares of Enhabit, Inc. at $8 per share on 10/10/2025, increasing his total holdings to 133,241 shares. The filing indicates the purchase was reported by an attorney-in-fact and lists the reporting person as a director. No derivative transactions or additional remarks were disclosed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Filing
Rhea-AI Summary

Enhabit, Inc. received a joint Schedule 13G/A reporting that a group of related investment entities and an individual, collectively the "Reporting Persons," hold 3,853,067 shares of Enhabit common stock, representing 7.61% of the outstanding class based on 50,637,417 shares outstanding. The holdings are held across affiliated vehicles: 8 Knots Fund (2,035,999 shares, 4.02%), 8 Knots Fund II (170,645 shares, 0.34%), and other affiliated entities that together account for the aggregate position.

The filing identifies 8 Knots Management, LLC as an SEC-registered investment adviser and names Scott Green as its managing member; 8 Knots Management and Mr. Green disclaim beneficial ownership of certain sub-advised and separately managed account positions, while acknowledging shared voting and dispositive power over the disclosed aggregate position. The filing includes a joint filing agreement among the Reporting Persons and a certification that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Solomon Ryan, Enhabit’s Chief Financial Officer, reported acquiring 10,000 shares of Enhabit common stock on 08/08/2025 at $7.64 per share (transaction code 'P', acquisition flag 'A'). The report shows his direct beneficial ownership increased to 193,468 shares. No derivative securities were reported in the filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Enhabit (EHAB)?

The current stock price of Enhabit (EHAB) is $7.75 as of October 10, 2025.

What is the market cap of Enhabit (EHAB)?

The market cap of Enhabit (EHAB) is approximately 405.5M.
Enhabit

NYSE:EHAB

EHAB Rankings

EHAB Stock Data

405.52M
48.91M
3.4%
102.87%
3.26%
Medical Care Facilities
Services-home Health Care Services
Link
United States
DALLAS